[引用][C] Néphropathie diabétique: IEC ou sartans?
M Laville - La Lettre du cardiologue, 2005 - pascal-francis.inist.fr
Néphropathie diabétique : IEC ou sartans ? CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Hypertension artérielle et néphropathie diabétique
N Nebti, H Baghous, HS Youcef, N Zenati… - Diabetes & …, 2013 - Elsevier
Introduction L'apparition d'une néphropathie chez le diabétique marque un tournant de
gravité en termes de risque cardiovasculaire. L'hypertension artérielle est une cause …
gravité en termes de risque cardiovasculaire. L'hypertension artérielle est une cause …
Nephropathy in type 2 diabetes
E Ritz - Journal of internal medicine, 1999 - Wiley Online Library
End‐stage renal failure (ESRF) in diabetic patients, mostly type 2, has become the most
frequent cause of renal replacement therapy in western Europe. The majority of patients with …
frequent cause of renal replacement therapy in western Europe. The majority of patients with …
[HTML][HTML] Irbesartan versus amlodipine pour la néphropathie diabétique
T Berl, LG Hunsicker, JB Lewis - Minerva, 2004 - minerva-ebp.be
Conclusion Cette analyse post-hoc d'une RCT ne montre pas de bénéfice de l'irbesartan par
rapport à l'amlodipine pour la prévention des événements cardiovasculaires chez les …
rapport à l'amlodipine pour la prévention des événements cardiovasculaires chez les …
Cardiovascular outcomes in diabetic nephropathy studies
P Thomson, M Fisher - Practical Diabetes International, 2006 - Wiley Online Library
Diabetes is associated with a high risk of the development of cardiovascular disease and
renal disease, and in patients with microalbuminuria this risk is further increased. Inhibition …
renal disease, and in patients with microalbuminuria this risk is further increased. Inhibition …
Prise en charge médicamenteuse de la néphropathie diabétique
B Bauduceau, L Bordier, L Monnier - Médecine des Maladies Métaboliques, 2023 - Elsevier
Résumé Le diabète est aujourd'hui une cause essentielle de maladie rénale chronique
(MRC) dont les conséquences sont majeures en termes de morbi-mortalité, de dégradation …
(MRC) dont les conséquences sont majeures en termes de morbi-mortalité, de dégradation …
Renin-angiotensin-aldosterone system blockers for diabetic nephropathy
AE Bagriy, MV Khomenko, ES Mikhailichenko - Vrach, 2021 - gynecology.orscience.ru
Diabetic nephropathy (DNP) is associated with a high risk of end-stage renal failure and an
unfavorable cardiovascular prognosis, which requires strict blood pressure and glycemic …
unfavorable cardiovascular prognosis, which requires strict blood pressure and glycemic …
Prognosis of diabetic nephropathy: how to improve the outcome
G Remuzzi, P Ruggenenti - Diabetes research and clinical practice, 1998 - Elsevier
Chronic renal diseases, including diabetic nephropathy, evolve to terminal renal failure by a
process leading to progressive parenchimal damage which appears relatively independent …
process leading to progressive parenchimal damage which appears relatively independent …
How high should an ACE inhibitor or angiotensin receptor blocker be dosed in patients with diabetic nephropathy?
MS Weinberg, N Kaperonis, GL Bakris - Current hypertension reports, 2003 - Springer
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs),
two drug classes that effectively block the actions of the renin-angiotensin system (RAS) …
two drug classes that effectively block the actions of the renin-angiotensin system (RAS) …
The changing trajectory of diabetic kidney disease
N Mistry, GL Bakris - Current Opinion in Nephrology and …, 2023 - journals.lww.com
The changing trajectory of diabetic kidney disease : Current Opinion in Nephrology and
Hypertension The changing trajectory of diabetic kidney disease : Current Opinion in …
Hypertension The changing trajectory of diabetic kidney disease : Current Opinion in …